Marimed (MRMD) Accounts Payables (2011 - 2026)

Marimed (MRMD) has 16 years of Accounts Payables data on file, last reported at $15.1 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 8.16% year-over-year to $15.1 million in Q1 2026; TTM through Mar 2026 was $15.1 million, a 8.16% increase from a year earlier, with the FY2025 full-year figure at $14.6 million, up 10.59% from the prior year.
• Accounts Payables for Q1 2026 stood at $15.1 million, up from $14.6 million in the prior quarter.
• Over the last five years, Accounts Payables for MRMD reached as high as $15.1 million in Q1 2026 and fell as low as $4.7 million in Q1 2023.
• Historically, Accounts Payables has averaged $10.3 million across 5 years, with a median of $10.3 million in 2024.
• Across the five-year window, Accounts Payables slumped 43.87% in 2023 and jumped 119.85% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $6.6 million in 2022, then soared by 35.84% to $9.0 million in 2023, then soared by 46.53% to $13.2 million in 2024, then grew by 10.59% to $14.6 million in 2025, then advanced by 3.59% to $15.1 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $15.1 million in Q1 2026, $14.6 million in Q4 2025, and $11.2 million in Q3 2025.